Helping transform medical discovery and innovation into viable solutions that can impact the world



Maximizing Value

Understanding market needs. Learn More »»

Portfolio Planning

Balancing technical difficulty of development with commercial attractiveness. Learn More »»

Informatics in Molecular Medicine

The use of multi-methodology algorithms in medical practice today. Learn More »»

The Role of Impact Modeling

Establishing the “value” in high-value diagnostics. Learn More »»

Delivering Diagnostics for Global Health

Understanding needs and developing diagnostic solutions that improve linkage to care in low resource settings. Learn More »»

Point of Care Testing

Renewed interest in decentralized or Point of Care Testing: what’s changed?. Learn More »»

Consumer Digital and Mobile Health

Understanding regulatory, payment and education challenges in the consumer digital health space. Learn More »»

Latest News

Cambridge Healthtech Institute’s 27th International Biodetection Technologies: Biothreat and Pathogen Detection June 17-18, 2019

Dr. Mickey S. Urdea will attend the 27th International Biodetection Technologies: Biothreat and Pathogen Detection Conference in Bethesda, Maryland. This internationally recognized meeting is for experts in detection and identification of biological threats. This conference addresses the key topics in pathogen detection and presents the latest R&D and technological innovations in ready-to-market systems. In addition, this meeting will focus on the latest strategies to overcoming the hurdles to the identification of global biological threats and translational gaps in bringing technologies from lab to field. Stimulating discussions, perspectives of end-users, high quality case studies will be featured and the opportunity to network with the leading experts in biodefense from around the globe will be provided.

Colorado State University IDRTalks July 8-10, 2019

Dr. Mickey S. Urdea will attend and present at the 2019 IDRTalks (Infectious Disease Research and Response Network) at Colorado State University in Fort Collins, CO and speak on “Why Diagnostics Companies Fail: Lessons Learned.”

71st AACC Annual Scientific Meeting August 4-8, 2019

Dr. Mickey S. Urdea and Mr. Richard M. Thayer will attend the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California. AACC provides an unparalleled opportunity to connect with global leaders in laboratory medicine and to discover cutting edge technology and learn about vital research in the field. AACC is the meeting place for global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.

November 2017 Diagnostics Report Issue 1 (PDF)



  • Business and Financial Modeling
  • Business Development
  • Clinical Studies and Regulatory
  • Global Sales and Marketing
  • Impact Modeling and Value Creation
  • Intellectual Property
  • Investor Presentations
  • Market and Technology Assessments
  • Medical Practice
  • Portfolio Planning
  • Product and Process Development
  • Strategic and Tactical Planning


  • Algorithms / Informatics / Health IT
  • Biomarker Discovery and Validation
  • Biostatistics
  • Companion Diagnostics
  • Digital Health and Wellness
  • Histology / Anatomic and Clinical Pathology
  • Immunodiagnostics
  • Instrument Systems
  • Life Science Research Tools
  • Medical Devices
  • Molecular Diagnostics
  • Next Generation Sequencing


  • Blood Screening
  • Chronic Diseases
  • Clinical Laboratory Services
  • Global Health
  • Infectious and Chronic Diseases
  • Life Science Research
  • Oncology
  • “Omics” applications
  • Parasitology
  • Pathology
  • Point of Care Testing
Scroll to Top